ACAM2000 DIN 02543699
Status: Restricted Access
Holder: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Molecule: VACCINIA VIRUS, LIVE
Available to quote
Health Canada record
| Active ingredient(s) | VACCINIA VIRUS, LIVE 1250000 PFU |
|---|---|
| Dosage form | Powder For Solution |
| Route | Percutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BX01 SMALLPOX AND MPOX VACCINES |
| Original market date | |
| Current status date | 20-Jun-2024 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32283 | 2023-12-05 | New Drug Submission (NDS) |